Work

Phase I study of dalteparin in combination with sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.e15607

Authors: Roberto Pili, Sumanta Kumar Pal, Saby George, Jens Voortman, Pongwut Danchaivijitr, Remi Adelaiye, Nancy Webb, Diane Poslinski, Adrienne Groman, Alan Hutson, Henk M.W. Verheul

Institutions: Roswell Park Comprehensive Cancer Center, City Of Hope National Medical Center, City of Hope, Amsterdam UMC Location Vrije Universiteit Amsterdam

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603096759

Cites:

Cited by:

Related to: 10